减肥药扩产计划遇阻！美国消费者团体要求FTC阻止诺和诺德(NVO.US ...
智通财经APP获悉，周四，美国消费者团体和两个大型工会敦促美国联邦贸易委员会(FTC)阻止诺和诺德(NVO.US)股东Novo Holdings收购合同药品制造商Catalent ...
格隆汇 on MSN8 小时
消费者团体要求美国FTC阻止Novo Holdings收购Catalent的交易
格隆汇10月18日｜据路透，美国消费者团体和两大工会周四敦促美国联邦贸易委员会(FTC)阻止诺和诺德控股股东Novo ...
消费者团体请愿FTC叫停诺和诺德-Catalent收购案
一个由消费者倡导组织和工会组成的联盟正敦促美国联邦贸易委员会 (FTC)阻止制药板块的一项重大收购。包括美国公共利益研究组织和服务业雇员国际工会 (SEIU)在内的消费者团体对Novo Holdings计划收购合同药品制造商Catalent表示担忧。这笔价值165亿美元的交易据称可能威胁到减肥药和创新基因疗法市场的竞争。
Consumer groups ask FTC to block Novo Holdings-Catalent deal
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...
Consumer, labor groups urge FTC to block Catalent sale to Novo Nordisk - report
Five U.S. consumer groups and two big labor unions are pushing for the Federal Trade Commission to block Novo Nordisk ...
Consumer, labor groups urge FTC to block Catalent sale to Novo Holdings - report
Financial groups and labor unions urge FTC to block Nordisk Foundation's acquisition of Catalent, citing concerns about ...
STAT4 小时
Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings
The coalition said in a letter sent to the FTC Thursday that the deal could reduce access to GLP-1s, and harm competition in ...
Zacks.com on MSN1 天
Catalent Stock Flat Following the Sell Agreement With Ardena
CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.
devdiscourse13 小时
FTC Urged to Block Novo's Acquisition of Catalent Over Competition Concerns
Consumer groups and labor unions urged the U.S. FTC to block Novo Holdings' $16.5 billion acquisition of Catalent, warning it ...
FiercePharma3 天
Catalent offloads New Jersey manufacturing plant, HQ to Belgian CDMO Ardena
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
NJBIZ2 天
Catalent to sell Somerset HQ
The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, ...
Catalent同意将新泽西州工厂出售给Ardena
合同制造服务提供商Catalent已达成协议，将其位于新泽西州萨默塞特的口服药物开发和小规模制造工厂出售给私人合同药品制造商Ardena。该交易于今日宣布。 这座获得美国食品和药物管理局(FDA)批准的萨默塞特工厂拥有约200名科学家和技术人员。Ardena表示，收购这座工厂将增强其在口服药物商业化生产方面的能力。 Catalent以其灌装完成工作而闻名，包括为制药公司进行注射器和注射笔的无菌灌装 ...